NanoBio Select@ expands the team
The UBI case NanoBio Select@ expands the team with laboratory assistant Iqra Nasir and senior engineer Nicolas Boulanger.
News
UBI aim to deepen Kvarken collaboration at Wasa Future Festival in Finland
As the summer holidays draw to a close, Umeå Biotech Incubator (UBI) is already busy getting back to work. On Thursday and Friday this week UBI Business Coach Pia Keyser will be at the Wasa Future Festival in Finland to talk about the life science collaboration in the Kvarken region.
Lipigon Pharmaceuticals signs USD 91 million deal with Leaderna Therapeutics
Lipigon Pharmaceuticals from Umeå is celebrating the signing of a development and license agreement for its clinical-stage drug candidate Lipisense® with Leaderna Therapeutics worth an estimated USD 91 million.
“We are delighted with this agreement and look forward to working with Leaderna on the future development of Lipisense®”, says Stefan K Nilsson, CEO of Lipigon. The new agreement specifically involves the development and licensing of the drug in Greater China.
New promising data with ColoNode for colon cancer
Umeå University, has in collaboration with HiloProbe AB completed the first part of a new clinical study of its ColoNode biomarker test, which provides further important evidence for the product ColoNode’s benefits and usefulness in colon cancer.
“The results look promising”, says Lina Olsson, CEO of Hiloprobe AB
Umeå Biotech Incubator granted SEK 14 million for the project “Life science city”
Umeå Biotech Incubator has been granted SEK 14 millions for the ERDF project “Life science city”, which will further develop the life science industry in the region 2024-2026.
”It feels gratifying that we get to build on our long-term goal”, says UBI’s Operations coordinator, Peter Jacobsson.
Assar Bäckman hangs up his lab coat and looks forward to retirement
He has been a vital part of Umeå Biotech Incubator (UBI) since its inception in 2003. But now, after 42 years of service in the biotech industry, it is time for respected research engineer Assar Bäckman to retire.
“My work has been hugely varied, and over the years I have learned a great deal. I usually have an emergency solution to most things if needed”, says Assar.
Peter Jacobsson appointed Operations Coordinator at Umeå Biotech Incubator
Jennie Ekbeck completed her final day as CEO of Umeå Biotech Incubator (UBI) last week. Experienced business coach Peter Jacobsson will now lead the business until a permanent replacement is appointed.
New collaboration hopes to make the most out of moss
The Umeå Biotech Incubator-backed ‘Shades of Green’ project, developed by Boreal Orchards, has created a moss that can be used on buildings, infrastructure and for the regeneration of nature. Now founder Daniel Pacurar is collaborating on a new development project with RISE Processum AB and Ecohelix to maximize moss establishment with the help of by-products from the paper pulp industry.
Jennie Ekbeck at Umeå Biotech Incubator receives an honorary doctorate
Jennie Ekbeck, CEO of Umeå Biotech Incubator, has been awarded an honorary doctorate for 2023 at the Faculty of Science and Technology at Umeå University.
“I want research to benefit people, that is my driving force,” she says.
UBI project awarded at Mötesplats Västerbotten: “Recognition for the work we have done”
Umeå Biotech Incubator (UBI) has won the Regio Stars Västerbotten 2023 award for its ‘Life Science Motorn 2.0’ regional fund project in the category “A region with localized sustainable business development”.
“It feels amazing that our project is being recognized and praised”, says UBI’s outgoing CEO, Jennie Ekbeck, who was the project manager behind the ‘Life Science Motorn 2.0’.
MedTech consultant company establishes in Umeå
Life science consulting company Orderly People has announced it will base one of its consultants in Umeå after the summer.
“There is a vibrant life science industry in Umeå which we want to be a part of”, says Orderly People’s founder and co-owner, Maria Jansson.
HiloProbe enters strategically important partnership with Biocartis
Umeå based HiloProbe AB has entered a partnership with the major international company Biocartis Group NV. This is a strategically important step for HiloProbe in their aim to reach out globally with its colorectal cancer test-product, ColoNode®.
“We are very happy to start a collaboration and a long-term relationship with Biocartis, which strengthens our focus on colorectal cancer thanks to Biocartis’ established sales and distribution network across many countries”, Lina Olsson, CEO of HiloProbe, says.
New international board promises to take Omnio to the next level
Umeå-based biopharmaceutical company Omnio AB, which is currently awaiting efficacy data from preclinical wound studies using recombinant plasminogen, has recently appointed an internationally experienced board of directors charged with taking the company forward.
“Our new board’s network and experience will allow us to build strategic partnerships with pharmaceutical and biotechnology companies, accelerate our clinical development program and ultimately bring our wound-healing candidate to market”, says Ulrika Norin, CEO of Omnio.
UBI hosts “Life science super week” with four events in three days
Umeå Biotech Incubator (UBI) is ending its development project program period with the “Life science super week” between May 8th-10th 2023 – an action-packed three-day event filled with seminars, an investment day, a life science pub plus a brand new services business fair.
“Life science in Umeå is buzzing right now, so pulling together several events at the same time gives us great synergistic effects”, says Jennie Ekbeck, UBI’s CEO.
Huge interest in emerging cancer treatment from G4 Cancer Cure
G4 Cancer Cure, a biotech research initiative located in Umeå in northern Sweden, has attracted considerable interest from doctors and the pharmaceutical industry for a new treatment method it is developing for triple-negative breast cancer.
Breast cancer is the most common cancer to affect women around the world, with approximately 15 percent of all cases diagnosed as triple-negative breast cancer. G4 Cancer Cure’s progress towards a treatment method is therefore being followed very closely, according to Project Manager Stefanie Sandberg.
“Our needs analysis shows there is huge interest in a new treatment method from doctors as well as pharmaceutical companies, experts and investors”, she says.
Umeå Biotech Incubator‘s CEO leaves for new challenges
The Board of Directors of Umeå Biotech Incubator (UBI) has announced that CEO Jennie Ekbeck is leaving her post after eleven years.
Kunskapsportalen för Life science-bolag vässas med nytt utbildningsmaterial
Sjösatt, uppskattad och under ständig utveckling. Kunskapsportalen vässas nu ytterligare med nytt utbildningsmaterial för flera efterfrågade områden.
– Vi ser att det är många olika forskare, entreprenörer och start-up företag som har hittat till plattformen. Vi hoppas att det nya innehållet ökar plattformens attraktionskraft ännu mer, säger Jennie Ekbeck, ordförande för Kunskapsportalens styrgrupp.
Five investors give multi-million backing to Vakona for new acne treatment
Umeå-based pharmaceutical company Vakona has been given a capital injection of just over SEK 14 million from five investors to help it develop a new drug to treat acne.
“This is a significant investment for us, as now we can continue with our product development”, says Gabriella Persson, CEO of Vakona.
Xerum nominated for the MedTech4Health Innovation Award
During the Covid pandemic, Xerum became nationally known for its self sampling and one of the world’s most sensitive antibody test. Now the Umeå company has been nominated for the prestigious MedTech4Health Innovation Award.